Tara Baetz, McGill University

Research

Image Mass Cytometry Immune Checkpoint Inhibitors Immunotherapy Melanoma Tumor Microenvironment Single Cell Epigenetic Profiling Single Cell Sequencing Single Cell Technology

Latest papers

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias
Blood advances · 2026
Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12
Journal of the National Cancer Institute · 2015
Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
Journal of Clinical Oncology · 2014

All 3 publications

Latest funding

Identification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma
CIHR · 2022 · Principal investigator
$1,422,900

All 1 grants and awards

3 publications.

01

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

Bhella S, Agbayani G, Hueniken K, Vijenthira A, Wilkin AM, Sebag M, Wang P, Hicks LK, Hay AE, Hosseini-Moghaddam SM

Blood advances2026

DOI: 10.1182/bloodadvances.2025018117

02

Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12

Cheung MC, Hay AE, Crump M, Imrie KR, Song Y, Hassan S, Risebrough N, Sussman J, Couban S, MacDonald D

Journal of the National Cancer Institute201522 citations

DOI: 10.1093/jnci/djv106

03

Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

Crump M, Kuruvilla J, Couban S, MacDonald DA, Kukreti V, Kouroukis CT, Rubinger M, Buckstein R, Imrie KR, Federico M

Journal of Clinical Oncology2014452 citations

DOI: 10.1200/jco.2013.53.9593

Identification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma

Principal investigatorCIHR2022Project Grant

Principal investigators: Watson, Ian R; Baetz, Tara; Dancey, Janet E; Song, Xinni

Keywords: Image Mass Cytometry; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma Tumor Microenvironment; Single Cell Epigenetic Profiling; Single Cell Sequencing; Single Cell Technology

$1,422,900

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Tom Kouroukis and Ralph Meyer: 27 shared papers
Michael Sebag and Donna Reece: 25 shared papers
Christopher Bredeson and David Allan: 24 shared papers
Donna Reece and Arleigh McCurdy: 23 shared papers
Michael Sebag and Arleigh McCurdy: 21 shared papers
Jonathan Sussman and Ralph Meyer: 19 shared papers
Natasha Kekre and David Allan: 19 shared papers
Natasha Kekre and Christopher Bredeson: 18 shared papers
Jonathan Sussman and Tom Kouroukis: 10 shared papers
Tom Kouroukis and Amaris Karin Balitsky: 9 shared papers
Amaris Karin Balitsky and Arleigh McCurdy: 6 shared papers
Ralph Meyer and John Kuruvilla: 5 shared papers
Jonathan Sussman and Amaris Karin Balitsky: 4 shared papers
Tom Kouroukis and John Kuruvilla: 4 shared papers
Amaris Karin Balitsky and Michael Sebag: 4 shared papers
Amaris Karin Balitsky and Curtis Cooper: 4 shared papers
Michael Sebag and Curtis Cooper: 4 shared papers
Natasha Kekre and Arleigh McCurdy: 4 shared papers
Jonathan Sussman and Nicole Mittmann: 3 shared papers
Shelly Bolotin and Shelly Bolotin: 3 shared papers
Shelly Bolotin and Shelly Bolotin: 3 shared papers
Shelly Bolotin and Shelly Bolotin: 3 shared papers
Jonathan Sussman and Tara Baetz: 2 shared papers
Tom Kouroukis and Christopher Bredeson: 2 shared papers
Tom Kouroukis and Tara Baetz: 2 shared papers
Amaris Karin Balitsky and David Allan: 2 shared papers
Ralph Meyer and Tara Baetz: 2 shared papers
Ralph Meyer and Nicole Mittmann: 2 shared papers
Curtis Cooper and Natasha Kekre: 2 shared papers
Jonathan Sussman and John Kuruvilla: 1 shared paper
Tom Kouroukis and Donna Reece: 1 shared paper
Tom Kouroukis and Nicole Mittmann: 1 shared paper
Amaris Karin Balitsky and Shelly Bolotin: 1 shared paper
Amaris Karin Balitsky and Shelly Bolotin: 1 shared paper
Amaris Karin Balitsky and Matthew Cheung: 1 shared paper
Amaris Karin Balitsky and Deepali Kumar: 1 shared paper
Amaris Karin Balitsky and James Brooks: 1 shared paper
Amaris Karin Balitsky and Natasha Kekre: 1 shared paper
Amaris Karin Balitsky and Tara Baetz: 1 shared paper
Amaris Karin Balitsky and Natasha Kekre: 1 shared paper
Amaris Karin Balitsky and Shelly Bolotin: 1 shared paper
Amaris Karin Balitsky and Stephen Betschel: 1 shared paper
Amaris Karin Balitsky and Michael Chu: 1 shared paper
Michael Sebag and Matthew Cheung: 1 shared paper
Michael Sebag and Deepali Kumar: 1 shared paper
Michael Sebag and James Brooks: 1 shared paper
Michael Sebag and Natasha Kekre: 1 shared paper
Michael Sebag and Tara Baetz: 1 shared paper
Michael Sebag and Natasha Kekre: 1 shared paper
Michael Sebag and Stephen Betschel: 1 shared paper
Michael Sebag and Michael Chu: 1 shared paper
Curtis Cooper and Matthew Cheung: 1 shared paper
Curtis Cooper and Deepali Kumar: 1 shared paper
Curtis Cooper and James Brooks: 1 shared paper
Curtis Cooper and Natasha Kekre: 1 shared paper
Curtis Cooper and Tara Baetz: 1 shared paper
Curtis Cooper and Natasha Kekre: 1 shared paper
Curtis Cooper and Stephen Betschel: 1 shared paper
Curtis Cooper and Michael Chu: 1 shared paper
Shelly Bolotin and Tara Baetz: 1 shared paper
Donna Reece and Tara Baetz: 1 shared paper
Shelly Bolotin and Tara Baetz: 1 shared paper
Matthew Cheung and Tara Baetz: 1 shared paper
John Kuruvilla and Tara Baetz: 1 shared paper
Deepali Kumar and Tara Baetz: 1 shared paper
James Brooks and Tara Baetz: 1 shared paper
Natasha Kekre and Tara Baetz: 1 shared paper
Natasha Kekre and Tara Baetz: 1 shared paper
Christopher Bredeson and Tara Baetz: 1 shared paper
Tara Baetz and Nicole Mittmann: 1 shared paper
Tara Baetz and Natasha Kekre: 1 shared paper
Tara Baetz and Shelly Bolotin: 1 shared paper
Tara Baetz and Arleigh McCurdy: 1 shared paper
Tara Baetz and David Allan: 1 shared paper
Tara Baetz and Stephen Betschel: 1 shared paper
Tara Baetz and Michael Chu: 1 shared paper

Department of Medicine
Oncology
Medicine
Infectious Diseases
Department of Surgery
Surgery
Pediatrics
Other

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Image Mass Cytometry Dear Professor Baetz, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Identification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Tara Baetz

Research

Latest papers

Latest funding

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12

Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

Identification of biomarkers using single cell technology that inform on optimal duration of immunotherapy treatment in melanoma

Frequent collaborators

Ralph Meyer

Tom Kouroukis

Jonathan Sussman

Nicole Mittmann

Natasha Kekre

Shelly Bolotin

Arleigh McCurdy

David Allan

Stephen Betschel

Michael Chu

Curtis Cooper

Shelly Bolotin

Donna Reece

Shelly Bolotin

Matthew Cheung

John Kuruvilla

Deepali Kumar

James Brooks

Natasha Kekre

Natasha Kekre

Christopher Bredeson

Amaris Karin Balitsky

Michael Sebag